# Supernus Pharmaceuticals to Participate in June Investor Conferences
Canonical URL: https://biopharmsignal.com/news/SUPN/supernus-pharmaceuticals-to-participate-in-june-investor-conferences
Ticker: SUPN
Company: Supernus
Source: Supernus
Published: 2026-06-25 13:46 EST
Original Source URL: https://ir.supernus.com
## Summary

ROCKVILLE, Md., May 27, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that management will participate in the

## Article Body
ROCKVILLE, Md., May 27, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that management will participate in the
## Recent Company News
- 2026-06-25 13:46 EST — [Supernus Pharmaceuticals to Participate in June Investor Conferences](https://biopharmsignal.com/news/SUPN/supernus-pharmaceuticals-to-participate-in-june-investor-conferences) — Source: Supernus
- 2026-06-25 13:46 EST — [Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference](https://biopharmsignal.com/news/SUPN/supernus-pharmaceuticals-to-participate-in-the-bank-of-america-2026-health-care-conference) — Source: Supernus
- 2026-06-25 13:46 EST — [Supernus Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025](https://biopharmsignal.com/news/SUPN/supernus-pharmaceuticals-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-november-4-2025) — Source: Supernus
- 2026-06-25 13:46 EST — [Supernus Announces Third Quarter 2025 Financial Results](https://biopharmsignal.com/news/SUPN/supernus-announces-third-quarter-2025-financial-results) — Source: Supernus
- 2026-06-25 13:46 EST — [Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London](https://biopharmsignal.com/news/SUPN/supernus-to-participate-in-the-2025-jefferies-global-healthcare-conference-in-london) — Source: Supernus
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)
- 2026-07-20 13:00 EST — ENLV — [Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion](https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9)